Home › Funds › ROYCE & ASSOCIATES LP › HCSG
ROYCE & ASSOCIATES LP position in HCSG
HEALTHCARE SVCS GROUP INC COM · Health Care
ROYCE & ASSOCIATES LP reported holding 2,239,224 shares of HCSG (HEALTHCARE SVCS GROUP INC COM) in its Q2 2026 13F filing — a position valued at US$55.0M, representing 0.44% of its reported portfolio and ranking #41 among its reported holdings. ROYCE & ASSOCIATES LP has disclosed HCSG holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ROYCE & ASSOCIATES LP's HCSG position evolved
ROYCE & ASSOCIATES LP first disclosed a stake in HCSG in Q3 2023 at 3,379,416 shares (US$35.2M). The position peaked in Q2 2026 at 2,239,224 shares, worth US$55.0M. Across 12 filings, ROYCE & ASSOCIATES LP increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,239,224 shares valued at US$55.0M — an increase of 95,987 shares quarter over quarter.. Notable position changes include a 35% trim in Q2 2025 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.38M | $35.25M | New |
| Q4 2023 | 3.91M | $40.59M | Add |
| Q1 2024 | 4.16M | $51.87M | Add |
| Q2 2024 | 4.16M | $44.00M | Hold |
| Q3 2024 | 4.45M | $49.70M | Add |
| Q4 2024 | 4.67M | $54.23M | Add |
| Q1 2025 | 4.68M | $47.22M | Hold |
| Q2 2025 | 3.04M | $45.62M | Reduce |
| Q3 2025 | 2.86M | $48.22M | Reduce |
| Q4 2025 | 2.29M | $43.84M | Reduce |
| Q1 2026 | 2.14M | $39.76M | Reduce |
| Q2 2026 | 2.24M | $55.00M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HCSG and 13F data
HCSG (HEALTHCARE SVCS GROUP INC COM) is a Health Care company. 38 other funds we track also report a position in HCSG — the largest reported positions include Royce & Associates (US$55.0M), Marathon Asset Management Ltd (US$18.7M), PALISADE CAPITAL MANAGEMENT, LP (US$17.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HCSG
- Royce & Associates 2.24M sh · $55.00M · Q2 2026
- Marathon Asset Management Ltd 759.82K sh · $18.66M · Q2 2026
- PALISADE CAPITAL MANAGEMENT, LP 726.58K sh · $17.84M · Q2 2026
- Pembroke Management, LTD 523.23K sh · $12.85M · Q2 2026
More on ROYCE & ASSOCIATES LP
FAQ
How long has ROYCE & ASSOCIATES LP held HCSG?
ROYCE & ASSOCIATES LP has disclosed HCSG holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ROYCE & ASSOCIATES LP's current position in HCSG?
As of Q2 2026, ROYCE & ASSOCIATES LP holds 2.24M shares of HCSG (HEALTHCARE SVCS GROUP INC COM), valued at $55.00M, representing 0.44% of its reported portfolio and ranking #41.
Has ROYCE & ASSOCIATES LP been buying or selling HCSG?
In the latest 13F filing (Q2 2026), ROYCE & ASSOCIATES LP increased its position in HCSG. The position peaked in Q2 2026 at 2.24M shares.
Which other funds hold HCSG?
Other major institutional holders of HCSG include Royce & Associates, Marathon Asset Management Ltd, PALISADE CAPITAL MANAGEMENT, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.